相关实验视频
Updated: Jan 18, 2026

05:17
Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
61.0K
概括
静脉注射免疫球蛋白 (IVIG) 可以导致新生儿严重贫血和交叉匹配问题. 抗人类球蛋白管方法 (AHG-管) 为IVIG注射后的兼容性测试提供了一个解决方案.
科学领域:
- 新生儿医学 新生儿医学
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 静脉注射免疫球蛋白 (IVIG) 用于新生儿治疗诸如败血症和死性肠球炎等疾病.
- IVIG的使用与严重的贫血和红细胞 (RBC) 输血并发症有关.
- 准确的红细胞选择对于接受IVIG的新生儿安全输血至关重要.
研究的目的:
- 调查新生儿IVIG后的严重贫血和交叉匹配不兼容性.
- 评估不同交叉匹配方法在IVIG后选择兼容的红细胞的有效性.
- 评估红细胞输血在接受IVIG治疗的新生儿的安全性和有效性.
主要方法:
- 在IVIG前后对新生儿样本进行了交叉匹配,直接抗球蛋白试验 (DAT),自由抗体试验 (FAT) 和化试验 (ET).
- 使用抗人类球蛋白微柱凝卡 (AHG卡) 和AHG管方法 (AHG管) 进行IVIG后交叉匹配.
- 收集了实验室结果,并对红细胞输血不良反应进行监测.
主要成果:
- 所有30名新生儿都显示出IVIG后的DAT,FAT和ET的正交叉匹配.
- 在IVIG后,乳酸脱酶 (LDH) 和胆红素的统计显著增加,红细胞和血红蛋白 (HGB) 的减少.
- AHG卡显示了30个不相容性,而AHG管只发现了6;红血细胞和HGB水平在输血后显著改善,没有不良事件.
结论:
- IVIG的使用可能会导致严重的贫血和交叉匹配困难,特别是在AHG卡方法中.
- 对新生儿进行谨慎的IVIG注射至关重要.
- 在IVIG后,AHG管方法是解决交叉匹配不兼容性的可行替代方案.
相关概念视频
Development of Immunocompetence
793
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
793
Blood Transfusion and Agglutination
14.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.0K
Rh Blood Group
2.8K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.8K
Blood Transfusion
2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K
Transcytosis of IgG
4.1K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.1K
Bone Marrow Sampling and Transplants
899
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
899

